Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns

Clinical Chemistry

Volumn 49, Issue 11, 2003, Pages 1797-1817

  Chace, Donald H ^a   Kalas, Theodore A ^a   Naylor, Edwin W ^a  

^a PERKINELMER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID;

AMINO ACID ANALYSIS; BLOOD ANALYSIS; FATTY ACID ANALYSIS; HUMAN; LABORATORY TEST; METABOLIC DISORDER; NEWBORN; NEWBORN SCREENING; REVIEW; TANDEM MASS SPECTROMETRY;

AMINO ACID METABOLISM, INBORN ERRORS; AMINO ACIDS; BLOOD SPECIMEN COLLECTION; CARNITINE; HEMATOLOGIC TESTS; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MASS SPECTROMETRY;

EID: 0242362630     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.022178     Document Type: Review

References (140)

1. Guthrie R. Screening for phenylketonuria. Triangle 1969;9:104-9.
2. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43.
3. Sweetman L. Newborn screening by tandem mass spectrometry (MS-MS) [Editorial]. Clin Chem 1996;42:345-6.
4. Sweetman L. Newborn screening by tandem mass spectrometry: gaining experience [Editorial]. Clin Chem 2001;47:1937-8.
5. Levy HL. Newborn screening by tandem mass spectrometry: a new era [Editorial]. Clin Chem 1998;44:2401-2.
6. Bennett MJ, Rinaldo P. The metabolic autopsy comes of age [Editorial]. Clin Chem 2001;47:1145-6.
7. Chace DH, Hillman SL, Van Hove JL, Naylor EW. Rapid diagnosis of MCAD deficiency: quantitatively analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997;43:2106-13.
8. Chace DH, Sherwin JE, Hillman SL, Lorey F, Cunningham GC. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours. Clin Chem 1998;44:2405-9.
9. Liebl B, Nennstiel-Ratzel U, von Kries R, Fingerhut R, Olgemoller B, Zapf A, et al. Expanded newborn screening in Bavaria: tracking to achieve requested repeat testing. Prev Med 2002;34:132-7.
10. Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, et al. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B Analyt Technol Biomed Life Sci 2002;776:39-48.
11. Filiano JJ, Bellimer SG, Kunz PL. Tandem mass spectrometry and newborn screening: pilot data and review. Pediatr Neurol 2002;26:201-4.
12. Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet 2002;3:17-45.
13. Carpenter KH, Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clin Chim Acta 2002;322:1-10.
14. Centers for Disease Control and Prevention. Using tandem mass spectrometry for metabolic disease screening among newborns: a report of a work group. MMWR Morb Mortal Wkly Rep 2001;50:1-22.
15. Carpenter K, Wiley V, Sim KG, Heath D, Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child Fetal Neonatal Ed 2001;85:F105-9.
16. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945-55.
17. Insinga RP, Laessig RH, Huffman GL. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel. J Pediatr 2002;141:524-31.
18. Chalmers RA, Lawson AM. Organic acids in man: analytical chemistry, biochemistry, and diagnosis of the organic acidurias. London: Chapman and Hall, 1982:523pp.
19. Goodman SI, Markey SP. Diagnosis of organic acidemias by gas chromatography-mass spectrometry. Lab Res Methods Biol Med 1981;6:1-158.
20. Niwa T. Metabolic profiling with gas chromatography-mass spectrometry and its application to clinical medicine. J Chromatogr 1986;379:313-45.
21. Duez P, Kumps A, Mardens Y. GC-MS profiling of urinary organic acids evaluated as a quantitative method. Clin Chem 1996;42:1609-15.
22. Kuhara T. Diagnosis of inborn errors of metabolism using filter paper urine, urease treatment, isotope dilution and gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 2001;758:3-25.
23. Kimura M, Yamamoto T, Yamaguchi S. Automated metabolic profiling and interpretation of GC/MS data for organic acidemia screening: a personal computer-based system. Tohoku J Exp Med 1999;188:317-34.
24. Kimura M, Yamamoto T, Yamaguchi S. A personal computer-based system for interpretation of gas chromatography mass spectrometry data in the diagnosis of organic acidaemias. Ann Clin Biochem 1999;36:671-2.
25. Chalmers RA, Roe CR, Stacey TE, Hoppel CL. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res 1984;18:1325-8.
26. Di Donato S, Rimoldi M, Garavaglia B, Uziel G. Propionylcarnitine excretion in propionic and methylmalonic acidurias: a cause of carnitine deficiency. Clin Chim Acta 1984;139:13-21.
27. Marzo A, Curti S. L-Carnitine moiety assay: an up-to-date reappraisal covering the commonest methods for various applications. J Chromatogr B Biomed Sci Appl 1997;702:1-20.
28. Bieber LL, Kerner J. Short-chain acylcarnitines: identification and quantitation. Methods Enzymol 1986;123:264-76.
29. Duran M, Ketting D, Beckeringh TE, Leupold D, Wadman SK. Direct identification of propionylcarnitine in propionic acidaemia: biochemical and clinical results of oral carnitine supplementation. J Inherit Metab Dis 1986;9:202-7.
30. Duran M, Ketting D, van Vossen R, Beckeringh TE, Dorland L, Bruinvis L, et al. Octanoylglucuronide excretion in patients with a defective oxidation of medium-chain fatty acids. Clin Chim Acta 1985;152:253-60.
31. Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Tracey BM, Millington DS. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child 1983;58:916-20.
32. Roe CR, Millington DS, Maltby DA. Identification of 3- methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3- methylglutaryl-coenzyme A lyase deficiency. J Clin Invest 1986;77:1391-4.
33. Roe CR, Millington DS, Maltby DA, Bohan TP, Hoppel CL. L-Carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 1984;73:1785-8.
34. Roe CR, Millington DS, Maltby DA, Bohan TP, Kahler SG, Chalmers RA. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1985;19:459-66.
35. Chai WG, Yan L, Wang GH, Liang XY, Zhao YF, Ji GJ. Improvement in sensitivity of fast atom bombardment mass spectrometry of amino acids by di-isopropylphosphorylation. Biomed Environ Mass Spectrom 1987;14:331-3.
36. Millington DS, Roe CR, Maltby DA. Characterization of new diagnostic acylcarnitines in patients with β-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. Biomed Environ Mass Spectrom 1987;14:711-6.
37. Millington DS, Norwood DL, Kodo N, Roe CR, Inoue F. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem 1989;180:331-9.
38. Millington DS, Roe CR, Maltby DA. Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Biomed Mass Spectrom 1984;11:236-41.
39. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-4.
40. Chace DH. Mass spectrometry in the clinical laboratory. Chem Rev 2001;101:445-77.
41. Chace DH. Measuring mass: from positive rays to proteins. Michael A Grayson, ed. [Book Review]. Clin Chem 2003;49:342-3.
42. Leonard JV, Dezateux C. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry [Editorial]. BMJ 2002;324:4-5.
43. Kushnir MM, Komaromy-Hiller G, Shushan B, Urry FM, Roberts WL. Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin Chem 2001;47:1993-2002.
44. Rolinski B, Arnecke R, Dame T, Kreischer J, Olgemoller B, Wolf E, et al. The biochemical metabolite screen in the Munich ENU Mouse Mutagenesis Project: determination of amino acids and acylcarnitines by tandem mass spectrometry. Mamm Genome 2000;11:547-51.
45. Millington D, Kodo N, Terada N, Roe D, Chace D. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom Ion Process 1991;111:211-28.
46. Fingerhut R, Roschinger W, Muntau AC, Dame T, Kreischer J, Arnecke R, et al. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem 2001;47:1763-8.
47. Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns [Technical Brief]. Clin Chem 2001;47:2040-4.
48. Stevens RD, Hillman SL, Worthy S, Sanders D, Millington DS. Assay for free and total carnitine in human plasma using tandem mass spectrometry [Technical Brief]. Clin Chem 2000;46:727-9.
49. Chace DH, Pons R, Chiriboga CA, McMahon DJ, Tein I, Naylor EW, et al. Neonatal blood carnitine concentrations: normative data by electrospray tandem mass spectrometry. Pediatr Res 2003;53:823-9.
50. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;39:66-71.
51. Dougherty FE, Levy HL. Present newborn screening for phenylketonuria. Ment Retard Dev Disabil Res Rev 1999;5:144-9.
52. Schulze A, Kohlmueller D, Mayatepek E. Sensitivity of electrospray-tandem mass spectrometry using the phenylalanine/tyrosine-ratio for differential diagnosis of hyperphenylalaninemia in neonates. Clin Chim Acta 1999;283:15-20.
53. Gempel K, Gerbitz KD, Casetta B, Bauer MF. Rapid determination of total homocysteine in blood spots by liquid chromatography-electrospray ionization-tandem mass spectrometry [Technical Brief]. Clin Chem 2000;46:122-3.
54. Magera MJ, Lacey JM, Casetta B, Rinaldo P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 1999;45:1517-22.
55. Rashed MS, Rahbeeni Z, Ozand PT. Screening blood spots for argininosuccinase deficiency by electrospray tandem mass spectrometry. Southeast Asian J Trop Med Public Health 1999;30(Suppl 2):170-3.
56. Trinh MU, Blake J, Harrison JR, Gerace R, Ranieri E, Fletcher JM, et al. Quantification of glutamine in dried blood spots and plasma by tandem mass spectrometry for the biochemical diagnosis and monitoring of ornithine transcarbamylase deficiency [Technical Brief]. Clin Chem 2003;49:681-4.
57. Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH, et al. Recoveries of phenylalanine from two sets of driedblood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix [Technical Brief]. Clin Chem 2000;46:126-8.
58. Chace DH, Adam BW, Smith SJ, Alexander JR, Hillman SL, Hannon WH. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clin Chem 1999;45:1269-77.
59. Hannon WH, Boyle J, Davin B, Marsden A, McCabe ERB, Schwartz M. Blood collection on filter paper for neonatal screening programs. NCCLS Document LA4-A3. Wayne, PA: NCCLS, 1997.
60. Therrell BL, Hannon WH, Pass KA, Lorey F, Brokopp C, Eckman J, et al. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med 1996;57:116-24.
61. Mei JV, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr 2001;131:1631S-6S.
62. Chace DH, Hillman SL, Millington DS, Kahler SG, Roe CR, Naylor EW. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem 1995;41:62-8.
63. Chace DH, Hillman SL, Millington DS, Kahler SG, Adam BW, Levy HL. Rapid diagnosis of homocystinuria and other hypermethi-oninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem 1996;42:349-55.
64. Millington DS, Terada N, Chace DH, Chen YT, Ding JH, Kodo N, et al. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. Prog Clin Biol Res 1992;375:339-54.
65. Millington DS, Norwood DL, Kodo N, Moore R, Green MD, Berman J. Biomedical applications of high-performance liquid chromatography-mass spectrometry with continuous-flow fast atom bombardment. J Chromatogr 1991;562:47-58.
66. Chace D, Millington D. Neonatal screening for inborn errors of metabolism by automated liquid secondary ion tandem mass spectrometry. In: Dhont J, ed. New horizons in neonatal screening, proceedings of the 9th International Neonatal Screening Symposium. Amsterdam: Elsevier, 1994:373-7.
67. Yergey AL, Liberato DJ, Millington DS. Thermospray liquid chromatography/mass spectrometry for the analysis of L-carnitine and its short-chain acyl derivatives. Anal Biochem 1984;139:278-83.
68. Rashed MS, Ozand PT, Harrison ME, Watkins PJF, Evans S. Electrospray tandem mass spectrometry in the analysis of organic acidemias. Rapid Commun Mass Spectrom 1994;8:122-33.
69. Vreken P, van Lint AE, Bootsma AH, Overmars H, Wanders RJ, van Gennip AH. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects. J Inherit Metab Dis 1999;22:302-6.
70. Shigematsu Y, Hata I, Kikawa Y, Mayumi M, Tanaka Y, Sudo M, et al. Modifications in electrospray tandem mass spectrometry for a neonatal-screening pilot study in Japan. J Chromatogr B Biomed Sci Appl 1999;731:97-103.
71. Rashed MS, Rahbeeni Z, Ozand PT. Application of electrospray tandem mass spectrometry to neonatal screening. Semin Perinatol 1999;23:183-93.
72. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
73. Rashed MS, Bucknall MP, Little D, Awad A, Jacob M, Alamoudi M, et al. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 1997;43:1129-41.
74. Chace DH. Quantitative, low cost, high throughput analysis of free carnitine in dried plasma specimens using MS/MS [Abstract]. 51st ASMS Conference. Montreal, Quebec, CA. J Am Soc Mass Spectrom 2003:14(Suppl 5S):20.
75. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001;47:1166-82.
76. Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med 2003;348:50-8.
77. Webster D, Dhondt JL, Hannon WH, Loeber G, Torresani T. Quality assurance and standardization: summary of the satellite meeting, Turku, Finland, 11-12 June 1999. Acta Paediatr Suppl 1999;88:7-12.
78. Wiley V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr Suppl 1999;88:48-51.
79. Naylor EW, Guthrie R. Newborn screening for maple syrup urine disease (branched-chain ketoaciduria). Pediatrics 1978;61:262-6.
80. Ogier de Baulny H, Saudubray JM. Branched-chain organic acidurias. Semin Neonatol 2002;7:65-74.
81. Ponzone A, Guardamagna O, Spada M, Ferraris S, Ponzone R, Kierat L, et al. Differential diagnosis of hyperphenylalaninaemia by a combined phenylalanine-tetrahydrobiopterin loading test. Eur J Pediatr 1993;152:655-61.
82. Reilly AA, Bellisario R, Pass KA. Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography. Clin Chem 1998;44:317-26.
83. Thomason MJ, Lord J, Bain MD, Chalmers RA, Littlejohns P, Addison GM, et al. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Public Health Med 1998;20:331-43.
84. Scriver CR. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill Health Professions Division, 1995:4605pp.
85. Shintaku H. [The metabolic basis of the hyperphenylalaninemias and tyrosinemia]. Nippon Rinsho 1992;50:1542-7.
86. Schulze A, Frommhold D, Hoffmann GF, Mayatepek E. Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I. Clin Chem 2001;47:1424-9.
87. Hou JW, Wang TR. Transient tyrosinemia presenting as lactic acidosis in a term baby: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1995;36:217-20.
88. Peterschmitt MJ, Simmons JR, Levy HL. Reduction of false negative results in screening of newborns for homocystinuria. N Engl J Med 1999;341:1572-6.
89. Johnson DW. Analysis of amino acids as formamidene butyl esters by electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2001;15:2198-205.
90. Stadler S, Gempel K, Bieger I, Pontz BF, Gerbitz KD, Bauer MF, et al. Detection of neonatal argininosuccinate lyase deficiency by serum tandem mass spectrometry. J Inherit Metab Dis 2001;24:370-8.
91. Roe CR, Cederbaum SD, Roe DS, Mardach R, Galindo A, Sweetman L. Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism. Mol Genet Metab 1998;65:264-71.
92. Tyni T, Pourfarzam M, Turnbull DM. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle. Pediatr Res 2002;52:64-70.
93. Okun JG, Kolker S, Schulze A, Kohlmueller D, Olgemoller K, Lindner M, et al. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. Biochim Biophys Acta 2002;1584:91-8.
94. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol 2002;64:477-502.
95. Clayton PT, Doig M, Ghafari S, Meaney C, Taylor C, Leonard JV, et al. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Arch Dis Child 1998;79:109-15.
96. Meyburg J, Schulze A, Kohlmueller D, Linderkamp O, Mayatepek E. Postnatal changes in neonatal acylcarnitine profile. Pediatr Res 2001;49:125-9.
97. Meyburg J, Schulze A, Kohlmueller D, Poschl J, Linderkamp O, Hoffmann GF, et al. Acylcarnitine profiles of preterm infants over the first four weeks of life. Pediatr Res 2002;52:720-3.
98. Osorio JH, Pourfarzam M. Plasma free and total carnitine measured in children by tandem mass spectrometry. Braz J Med Biol Res 2002;35:1265-71.
99. Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr 2001;138:581-4.
100. Sim KG, Wiley V, Carpenter K, Wilcken B. Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile. J Inherit Metab Dis 2001;24:51-9.
101. Koeberl DD, Young SP, Gregersen N, Vockley J, Smith WE, Benjamin DK Jr, et al. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectroscopy newborn screening. Pediatr Res 2003;54:1-5.
102. Duran M, Bruinvis L, Ketting D, de Klerk JB, Wadman SK. cis-4-Decenoic acid in plasma: a characteristic metabolite in medium-chain acyl-CoA dehydrogenase deficiency. Clin Chem 1988;34:548-51.
103. Van Hove JL, Zhang W, Kahler SG, Roe CR, Chen YT, Terada N, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. Am J Hum Genet 1993;52:958-66.
104. Andresen BS, Dobrowolski SF, O'Reilly L, Muenzer J, McCandless SE, Frazier DM, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 2001;68:1408-18.
105. Poplawski NK, Ranieri E, Harrison JR, Fletcher JM. Multiple acyl-coenzyme A dehydrogenase deficiency: diagnosis by acylcarnitine analysis of a 12-year-old newborn screening card. J Pediatr 1999;134:764-6.
106. Naylor EW, Chace DH. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 1999;14(Suppl 1):S4-8.
107. Abdenur JE, Chamoles NA, Schenone AB, Jorge L, Guinle A, Bernard C, et al. Multiple acyl-CoA-dehydrogenase deficiency (MADD): use of acylcarnitines and fatty acids to monitor the response to dietary treatment. Pediatr Res 2001;50:61-6.
108. Wood JC, Magera MJ, Rinaldo P, Seashore MR, Strauss AW, Friedman A. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card. Pediatrics 2001;108:E19.
109. Touma EH, Rashed MS, Vianey-Saban C, Sakr A, Divry P, Gregersen N, et al. A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency. Arch Dis Child 2001;84:58-60.
110. Matern D, Strauss AW, Hillman SL, Mayatepek E, Millington DS, Trefz FK. Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis. Pediatr Res 1999;46:45-9.
111. Van Hove JL, Kahler SG, Feezor MD, Ramakrishna JP, Hart P, Treem WR, et al. Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Inherit Metab Dis 2000;23:571-82.
112. Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P, Burlina AB. Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res 1996;39:185-8.
113. Abdenur JE, Chamoles NA, Guinle AE, Schenone AB, Fuertes AN. Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme. J Inherit Metab Dis 1998;21:624-30.
114. MacCoss MJ, Fukagawa NK, Matthews DE. Measurement of homocysteine concentrations and stable isotope tracer enrichments in human plasma. Anal Chem 1999;71:4527-33.
115. Matern D, He M, Berry SA, Rinaldo P, Whitley CB, Madsen PP, et al. Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics 2003;112:74-8.
116. Gibson KM, Burlingame TG, Hogema B, Jakobs C, Schutgens RB, Millington D, et al. 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: a new inborn error of L-isoleucine metabolism. Pediatr Res 2000;47:830-3.
117. Andresen BS, Christensen E, Corydon TJ, Bross P, Pilgaard B, Wanders RJ, et al. Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism. Am J Hum Genet 2000;67:1095-103.
118. Zschocke J, Ruiter JP, Brand J, Lindner M, Hoffmann GF, Wanders RJ, et al. Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl- CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatr Res 2000;48:852-5.
119. Morton DH, Bennett MJ, Seargeant LE, Nichter CA, Kelley RI. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am J Med Genet 1991;41:89-95.
120. Greenberg CR, Prasad AN, Dilling LA, Thompson JR, Haworth JC, Martin B, et al. Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 2002;75:70-8.
121. Smith WE, Millington DS, Koeberl DD, Lesser PS. Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics 2001;107:1184-7.
122. Santer R, Fingerhut R, Lassker U, Wightman PJ, Fitzpatrick DR, Olgemoller B, et al. Tandem mass spectrometric determination of malonylcarnitine: diagnosis and neonatal screening of malonyl-CoA decarboxylase deficiency. Clin Chem 2003;49:660-2.
123. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003;348:2304-12.
124. Bellisario R, Colinas RJ, Pass KA. Simultaneous measurement of thyroxine and thyrotropin from newborn dried blood-spot specimens using a multiplexed fluorescent microsphere immunoassay. Clin Chem 2000;46:1422-4.
125. Bellisario R, Colinas RJ, Pass KA. Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood-spot specimens using a multiplexed microsphere-based immunoassay. Early Hum Dev 2001;64:21-5.
126. Swartzman EE, Miraglia SJ, Mellentin-Michelotti J, Evangelista L, Yuan PM. A homogeneous and multiplexed immunoassay for high-throughput screening using fluorometric microvolume assay technology. Anal Biochem 1999;271:143-51.
127. Dobrowolski SF, Banas RA, Naylor EW, Powdrill T, Thakkar D. DNA microarray technology for neonatal screening. Acta Paediatr Suppl 1999;88:61-4.
128. McCabe ER, McCabe LL. State-of-the-art for DNA technology in newborn screening. Acta Paediatr Suppl 1999;88:58-60.
129. McCabe ER. DNA techniques for screening of inborn errors of metabolism. Eur J Pediatr 1994;153:S84-5.
130. Wasant P, Naylor EW, Liammongkolkul S. Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants. Southeast Asian J Trop Med Public Health 1999;30(Suppl 2):154-9.
131. Bennett MJ, Hale DE, Coates PM, Stanley CA. Postmortem recognition of fatty acid oxidation disorders. Pediatr Pathol 1991;11:365-70.
132. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 1998;132:924-33.
133. Boles RG, Martin SK, Blitzer MG, Rinaldo P. Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. Hum Pathol 1994;25:735-41.
134. Rinaldo P, Stanley CA, Hsu BY, Sanchez LA, Stern HJ. Sudden neonatal death in carnitine transporter deficiency. J Pediatr 1997;131:304-5.
135. Lundemose JB, Kolvraa S, Gregersen N, Christensen E, Gregersen M. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. Mol Pathol 1997;50:212-7.
136. Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindaraju DR, Rinaldo P. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 1995;41:1109-14.
137. Mueller P, Schulze A, Schindler I, Ethofer T, Buehrdel P, Ceglarek U. Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clin Chim Acta 2003;327:47-57.
138. Braida L, Crovella S, Boniotto M, Luchesi A, de Vonderweid U, Casetta B, et al. A rapid and quantitative mass spectrometry method for determining the concentration of acylcarnitines and aminoacids in amniotic fluid. Prenat Diagn 2001;21:543-6.
139. Shigematsu Y, Hata I, Nakai A, Kikawa Y, Sudo M, Tanaka Y, et al. Prenatal diagnosis of organic acidemias based on amniotic fluid levels of acylcarnitines. Pediatr Res 1996;39:680-4.
140. Chace DH. Mass spectrometry-based diagnostics: the upcoming revolution in disease detection has already arrived [Letter]. Clin Chem 2003;49:1227-8; author reply 1228-9.